Jaguar Health, Inc.
(NASDAQ : JAGX)

( )
JAGX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Generic
symbolcompany%chnglast%shortavg$volume
AGNAllergan plc
-1.03%138.752.8%$305.02m
ZTSZoetis, Inc. Class A
0.23%102.201.9%$195.68m
MYLMylan N.V.
-1.12%19.423.2%$182.88m
TEVATeva Pharmaceutical Industries Limited Sponsored ADR
-1.20%11.492.0%$176.58m
TXMDTherapeuticsMD, Inc.
-1.20%3.2924.9%$12.62m
PETXAratana Therapeutics, Inc.
-0.62%4.858.5%$10.30m
TAROTaro Pharmaceutical Industries Ltd.
-0.24%100.306.4%$6.43m
RDYDr. Reddy's Laboratories Ltd. Sponsored ADR
-5.84%37.082.0%$5.42m
ABEOAbeona Therapeutics, Inc.
-1.34%7.347.6%$2.77m
KINKindred Biosciences, Inc.
0.12%8.410.3%$1.60m
LFVNLifeVantage Corporation
-0.35%11.463.3%$1.29m
JAGXJaguar Animal Health, Inc.
-9.91%0.199.8%$0.62m
CPHIChina Pharma Holdings, Inc.
-5.07%0.280.1%$0.09m

Company Profile

Jaguar Health, Inc. is a commercial stage pharmaceuticals company, which engages in the development of gastrointestinal products. Its products include Canalevia, Equilevia, and Neonorm. It operates through the Human Health and Animal Health segments. The Human Health segment manufactures human products and the ongoing advertising of Mytesi, which is used for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The Animal Health segment commercializes prescription and non-prescription products for companion and production animals. The company was founded by Lisa A. Conte on June 6, 2013 and is headquartered in San Francisco, CA.